A New Breast Cancer Discovery Strategy: A Combined Outlier Rejection Technique and an Ensemble Classification Method

Abstract

Annually, many people worldwide lose their lives due to breast cancer, making it one of the most prevalent cancers in the world. Since the disease is becoming more common, early detection of breast cancer is essential to avoiding serious complications and possibly death as well. This research provides a novel Breast Cancer Discovery (BCD) strategy to aid patients by providing prompt and sensitive detection of breast cancer. The two primary steps that form the BCD are the Breast Cancer Discovery Step (BCDS) and the Pre-processing Step (P2S). In the P2S, the needed data are filtered from any non-informative data using three primary operations: data normalization, feature selection, and outlier rejection. Only then does the diagnostic model in the BCDS for precise diagnosis begin to be trained. The primary contribution of this research is the novel outlier rejection technique known as the Combined Outlier Rejection Technique (CORT). CORT is divided into two primary phases: (i) the Quick Rejection Phase (QRP), which is a quick phase utilizing a statistical method, and (ii) the Accurate Rejection Phase (ARP), which is a precise phase using an optimization method. Outliers are rapidly eliminated during the QRP using the standard deviation, and the remaining outliers are thoroughly eliminated during ARP via Binary Harris Hawk Optimization (BHHO). The P2S in the BCD strategy indicates that data normalization is a pre-processing approach used to find numeric values in the datasets that fall into a predetermined range. Information Gain (IG) is then used to choose the optimal subset of features, and CORT is used to reject incorrect training data. Furthermore, based on the filtered data from the P2S, an Ensemble Classification Method (ECM) is utilized in the BCDS to identify breast cancer patients. This method consists of three classifiers: Naïve Bayes (NB), K-Nearest Neighbors (KNN), and Support Vector Machine (SVM). The Wisconsin Breast Cancer Database (WBCD) dataset, which contains digital images of fine-needle aspiration samples collected from patients’ breast masses, is used herein to compare the BCD strategy against several contemporary strategies. According to the outcomes of the experiment, the suggested method is very competitive. It achieves 0.987 accuracy, 0.013 error, 0.98 recall, 0.984 precision, and a run time of 3 s, outperforming all other methods from the literature.